According to Prime Medicine's latest financial reports the company has $0.19 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $0.19 B | 56.53% |
2023-12-31 | $0.12 B | -58.61% |
2022-12-31 | $0.29 B | 9.01% |
2021-12-31 | $0.26 B | 405.59% |
2020-12-31 | $53.32 M |